181 related articles for article (PubMed ID: 15938990)
1. Minimizing the risk for QT interval prolongation.
Slama TG
J Fam Pract; 2005 Jun; Suppl():S15-7. PubMed ID: 15938990
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic agents associated with QT interval prolongation.
Olsen KM
J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
[TBL] [Abstract][Full Text] [Related]
3. Identifying patients at risk for QT interval prolongation: case studies.
Flyer JL
J Fam Pract; 2005 Jun; Suppl():S18-9. PubMed ID: 15938991
[No Abstract] [Full Text] [Related]
4. Drug-induced QT prolongation.
Michowitz MK; Michowitz Y; Zaidenstien R; Golik A
Isr Med Assoc J; 2000 Dec; 2(12):924-8. PubMed ID: 11344777
[No Abstract] [Full Text] [Related]
5. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Shantsila E; Watson T; Lip GY
Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
[TBL] [Abstract][Full Text] [Related]
6. Acquired QT prolongation.
Cahoon WD
Prog Cardiovasc Nurs; 2009 Mar; 24(1):30-3. PubMed ID: 19261141
[No Abstract] [Full Text] [Related]
7. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
9. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
[TBL] [Abstract][Full Text] [Related]
10. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
11. Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between?
Kanters JK; Graff C; Andersen MP; Hardahl T; Toft E; Christiansen M; Bloch Thomsen PE; Struijk JJ
J Electrocardiol; 2006 Oct; 39(4 Suppl):S119-22. PubMed ID: 16920146
[TBL] [Abstract][Full Text] [Related]
12. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
[TBL] [Abstract][Full Text] [Related]
13. What is QT interval prolongation?
Vorchheimer DA
J Fam Pract; 2005 Jun; Suppl():S4-7. PubMed ID: 15938992
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
16. Molecularly targeted oncology therapeutics and prolongation of the QT interval.
Strevel EL; Ing DJ; Siu LL
J Clin Oncol; 2007 Aug; 25(22):3362-71. PubMed ID: 17664484
[TBL] [Abstract][Full Text] [Related]
17. Value of history-taking in syncope patients: in whom to suspect long QT syndrome?
Colman N; Bakker A; Linzer M; Reitsma JB; Wieling W; Wilde AA
Europace; 2009 Jul; 11(7):937-43. PubMed ID: 19482852
[TBL] [Abstract][Full Text] [Related]
18. Is flecainide dangerous in long QT-3 patients?
Beinart R; Michailidis A; Gurevitz OT; Glikson M
Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
[TBL] [Abstract][Full Text] [Related]
19. [Preventive treatment of prolongation of the QT interval].
Szponar J; Zapalska-Pozarowska K; Szponar E
Przegl Lek; 2012; 69(8):535-40. PubMed ID: 23243922
[TBL] [Abstract][Full Text] [Related]
20. [Psychiatric patients and QT interval monitoring].
Girardin F; Gaspoz JM
Rev Med Suisse; 2007 Apr; 3(106):945-8. PubMed ID: 17575970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
